Home

Schleichen Tor ein Feuer anzünden richard pops alkermes Mehlschwitze Defekt Aufsatz

Richard Pops, chief executive officer of Alkermes Plc, speaks during...  News Photo - Getty Images
Richard Pops, chief executive officer of Alkermes Plc, speaks during... News Photo - Getty Images

Leadership, Management Team & Board of Directors | Alkermes
Leadership, Management Team & Board of Directors | Alkermes

Richard Pops - CEO @ Alkermes - Crunchbase Person Profile
Richard Pops - CEO @ Alkermes - Crunchbase Person Profile

Alkermes prefers independence and opts out of takeover trend
Alkermes prefers independence and opts out of takeover trend

Drug tech firm Alkermes bullish despite reporting full-year loss
Drug tech firm Alkermes bullish despite reporting full-year loss

Moving From Crisis To Lasting Change
Moving From Crisis To Lasting Change

Alkermes expands pipeline, launches Phase 2 trial - Boston Business Journal
Alkermes expands pipeline, launches Phase 2 trial - Boston Business Journal

Richard Pops
Richard Pops

Alkermes stock surges on depression drug's success
Alkermes stock surges on depression drug's success

Alkermes shares slump after watchdog blow to drug trial - Independent.ie
Alkermes shares slump after watchdog blow to drug trial - Independent.ie

Leadership, Management Team & Board of Directors | Alkermes
Leadership, Management Team & Board of Directors | Alkermes

Alkermes Inspiration Grants® | Alkermes
Alkermes Inspiration Grants® | Alkermes

Leadership, Management Team & Board of Directors | Alkermes
Leadership, Management Team & Board of Directors | Alkermes

Discount offering nets $250m for Alkermes - Independent.ie
Discount offering nets $250m for Alkermes - Independent.ie

Leadership, Management Team & Board of Directors | Alkermes
Leadership, Management Team & Board of Directors | Alkermes

Alkermes Has Launched Employee Resource Groups | News Direct
Alkermes Has Launched Employee Resource Groups | News Direct

Biotech stock Alkermes plunges 20% after FDA refuses to review its  depression treatment
Biotech stock Alkermes plunges 20% after FDA refuses to review its depression treatment

Leadership, Management Team & Board of Directors | Alkermes
Leadership, Management Team & Board of Directors | Alkermes

Richard Pops, chairman and chief executive officer of Alkermes Plc,... News  Photo - Getty Images
Richard Pops, chairman and chief executive officer of Alkermes Plc,... News Photo - Getty Images

Leadership, Management Team & Board of Directors | Alkermes
Leadership, Management Team & Board of Directors | Alkermes

Alkermes CEO & Leadership Team Ratings | Comparably
Alkermes CEO & Leadership Team Ratings | Comparably

Alkermes CEO nets $3.5M in stock sales since April - Boston Business Journal
Alkermes CEO nets $3.5M in stock sales since April - Boston Business Journal

Richard Pops, chief executive officer of Alkermes Plc, listens during...  News Photo - Getty Images
Richard Pops, chief executive officer of Alkermes Plc, listens during... News Photo - Getty Images

Alkermes plunges after depression drug fails in two clinical trials - The  Boston Globe
Alkermes plunges after depression drug fails in two clinical trials - The Boston Globe